ScholarIQanswers from OpenAlex & ORCID
Giuseppe Aprile
ResearcherPublications, citations & collaboration network
Giuseppe Aprile is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Giuseppe Aprile have?
ScholarIQindexed works
Giuseppe Aprile has 522 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Giuseppe Aprile have?
ScholarIQcitation count
Giuseppe Aprile has 22,705 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Giuseppe Aprile?
ScholarIQh-index
Giuseppe Aprile has an h-index of 57 in OpenAlex.
What is the i10-index of Giuseppe Aprile?
ScholarIQi10-index
Giuseppe Aprile has an i10-index of 203 in OpenAlex.
What is the ORCID of Giuseppe Aprile?
ScholarIQorcid
The ORCID for Giuseppe Aprile is on the source record.
What is the OpenAlex record for Giuseppe Aprile?
ScholarIQopenalex
The OpenAlex for Giuseppe Aprile is on the source record.
What are the most-cited papers on Giuseppe Aprile?
ScholarIQmost cited works
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Charles S. Fuchs, Jiří Tomášek, Cho Jae Yong, Filip Dumitru, Rodolfo Passalacqua, Chanchal Goswami, Howard Safran, Lucas Vieira dos Santos, Giuseppe Aprile, David Ferry, Bohuslav Melichar, Mustapha Tehfé, Э. Э. Топузов, John Zalcberg, Ian Chau, William Campbell, Choondal Devan Sivanandan, Joanna Pikiel, Minori Koshiji, Yanzhi Hsu, Astra M. Liepa, Ling Gao, Jonathan D. Schwartz, Josep Tabernero
Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan
Chiara Cremolini, Daniele Rossini, Emanuela Dell’Aquila, Sara Lonardi, Elena Conca, Marzia Del Re, Adele Busico, Filippo Pietrantonio, Romano Danesi, Giuseppe Aprile, Emiliano Tamburini, Carlo Barone, Gianluca Masi, Francesco Pantano, Francesca Pucci, Domenico Corsi, Nicoletta Pella, Francesca Bergamo, Eleonora Rofi, C. Barbara, Alfredo Falcone, Daniele Santini
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial
Charles S. Fuchs, Kohei Shitara, Maria Di Bartolomeo, Sara Lonardi, Salah‐Eddin Al‐Batran, Eric Van Cutsem, David H. Ilson, María Alsina, Ian Chau, Jill Lacy, Michel Ducreux, Guillermo Ariel Mendez, Alejandro Molina Alavez, Daisuke Takahari, Wasat Mansoor, Peter C. Enzinger, Vera Gorbounova, Zev A. Wainberg, Susanna Hegewisch‐Becker, David Ferry, Ji Lin, Roberto Carlesi, Mayukh Das, Manish A. Shah, Alexander Luft, Nina Karaseva, Rubén Dario Kowalyszyn, Carlos Alberto Hernández, Tibor Csőszi, Ferdinando De Vita, Per Pfeiffer, Naotoshi Sugimoto, Judit Kocsis, Andràs Csilla, G. Bodoky, Georgina Garnica Jaliffe, Светлана Проценко, Ayman Madi, Elżbieta Wójcik, Baruch Brenner, Gunnar Folprecht, Tomasz Sarosiek, Katriina Peltola, Peter Bono, Hubert Ayala, Giuseppe Aprile, Cardellino Giovanni Gerardo, Fidel David Huitzil Melendez, Alfredo Falcone, Francesco Di Costanzo, Moustapha Tehfe, Laurent Mineur, Pilar Alfonso, Radka Obermannová, Hélène Senellart, Russell Petty, Leslie Samuel, Péter Ács, Maen Hussein, M. Nechaeva, Frans Erdkamp, Elizabeth Won, Johanna C. Bendell, Javier Gállego, Sylvie Lorenzen, Bohuslav Melichar, Miguel Angel Escudero, Denis Pezet, Jean–Marc Phelip, Diego Kaen, James A. Reeves, Federico Longo Muñoz, Srinivasan Madhusudan, Carlo Barone, Luis Fein, Ángel Gómez Villanueva, Mohamed Hebbar, Jana Prausová, L. Visa Turmo, J. Vidal Barrull, Mette Yilmaz, Alex Beny, Hanneke W.M. van Laarhoven, Brian DiCarlo, Taito Esaki, Kazumasa Fujitani, Karen Geboes, Ravit Geva, Shigenori Kadowaki, Stephen Leong, Nozomu Machida, Moses S. Raj, Francisco Javier Ramírez Godinez, Ágnes Ruzsa, Hugo Ford, William Lawler, Nicolas Robert Maisey, Jiřı́ Petera, Einat Shacham‐Shmueli, Isabelle Sinapi